FrancophonIA/ELRC3.0 huggingface dataset:
English: What Binocrit contains - The active substance is: epoetin alfa (for quantity see the table below).
Danish: - Aktivt stof: epoetin alfa (se tabellen nedenfor for kvantiteter).
English: If you forget to use Binocrit
Danish: Hvis du har glemt at tage Binocrit
English: Binocrit may be given by injection:
Danish: Binocrit kan gives som en indsprøjtning:
English: You may still be able to use Binocrit, but discuss it with your doctor first:
Danish: Det er muligt, at du stadig kan bruge Binocrit, men du skal først tale med lægen om det:
English: The recommended dose is Binocrit 600 IU/kg, administered subcutaneously weekly for three weeks (days -21, -14 and -7) prior to surgery and on the day of surgery (day 0).
Danish: Den anbefalede Binocrit-dosis er 600 IE/kg subkutant ugentligt i 3 uger (på dag - 21, - 14 og - 7) forud for operationsdagen samt på selve operationsdagen (dag 0).
English: You may still be able to use Binocrit, but discuss it with your doctor first.
Danish: Det kan være, at det stadig er muligt at bruge Binocrit, men du skal først tale med lægen om det.
English: Instructions on how to inject Binocrit yourself
Danish: Vejledninger i, hvordan du selv skal indsprøjte Binocrit
English: Where intravenous access is not readily available (patients not yet undergoing dialysis and peritoneal dialysis patients) Binocrit may be administered as a subcutaneous injection.
Danish: Hvis intravenøs adgang ikke er umiddelbart tilgængelig (patienter, som endnu ikke er i dialyse, og peritonealdialysepatienter), kan Binocrit administreres som subkutan injektion.
English: Patients should be monitored closely to ensure that the lowest approved effective dose of Binocrit is used to provide adequate control of anaemia and of the symptoms of anaemia whilst maintaining a haemoglobin concentration below or at 12 g/dL (7.5 mmol/L).
Danish: Patienter skal monitoreres nøje for at sikre, at der anvendes den laveste godkendte effektive dosis Binocrit til at opnå tilstrækkelig kontrol med anæmi og af anæmisymptomerne under opretholdelse af en hæmoglobinkoncentration under eller på 12 g/dl (7,5 mmol/l).
English: Binocrit is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.
Danish: Binocrit er indiceret hos voksne, der er i behandling med kemoterapi for alvorlige tumorer, malignt lymfom eller myelomatose samt ved risiko ved transfusion pga. patientens almentilstand (f.eks. dennes kardiovaskulære status eller allerede eksisterende anæmi ved start af kemoterapi) til behandling af anæmi og til nedsættelse af transfusionsbehovet.
English: • in adults on haemodialysis or peritoneal dialysis
Danish: • hos voksne patienter i hæmodialyse eller peritonealdialyse
English: Binocrit is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.
Danish: Binocrit er indiceret hos voksne uden jernmangel forud for større elektive ortopædkirurgiske operationer, der indebærer en risiko for transfusionskomplikationer, til at nedsætte brugen af allogene blodtransfusioner.
English: Take special care with Binocrit:
Danish: Vær særligt forsigtig med Binocrit:
English: Binocrit should not be used:
Danish: Binocrit må ikke anvendes:
English: Binocrit is used to treat symptomatic anaemia caused by kidney disease:
Danish: Binocrit bruges til at behandle symptomatisk anæmi forårsaget af nyresygdom:
English: What you need to know before you use Binocrit
Danish: Det skal du vide, før du begynder at tage Binocrit
English: Binocrit is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Danish: Binocrit anvendes til at behandle anæmi hos voksne med en knoglemarvssygdom, der medfører svære forstyrrelser i dannelsen af blodlegemer (myelodysplastiske syndromer).
English: Binocrit is not approved in the management of anaemia associated with hepatitis C.
Danish: Binocrit er ikke godkendt til behandling af anæmi forbundet med hepatitis C.
English: If you are a patient with chronic renal failure, and particularly if you do not respond properly to Binocrit, your doctor will check your dose of Binocrit because repeatedly increasing your dose of Binocrit if you are not responding to treatment may increase the risk of having a problem of the heart or the blood vessels and could increase risk of myocardial infarction, stroke and death.
Danish: Hvis du har kronisk nyreinsufficiens, og især hvis du ikke reagerer korrekt på Binocrit, vil din læge kontrollere din Binocrit-dosis, da du har større risiko for at få et problem med hjertet eller blodkarrene, hvis din Binocrit-dosis skal øges gentagne gange, fordi du ikke reagerer på behandlingen.
English: In cases where there is a medical need to shorten the lead time before surgery to less than three weeks, Binocrit 300 IU/kg should be administered subcutaneously daily for 10 consecutive days prior to surgery, on the day of surgery and for four days immediately thereafter.
Danish: I tilfælde, hvor der er en klinisk årsag til at afkorte behandlingstiden før operationen til mindre end tre uger, skal Binocrit 300 IE/kg administreres subkutant dagligt i 10 dage før operationen, på selve operationsdagen samt i de 4 første dage umiddelbart efter operationen.
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Binocrit should be stopped and further dosages should not be administered.
Danish: Hvis hæmoglobinværdien når 15 g/dl (9,38 mmol/l) eller derover i løbet af den præoperative periode, skal indgiften af Binocrit stoppes og yderligere doser ikke administreres.
English: Do not use Binocrit:
Danish: Tag ikke Binocrit:
English: Binocrit is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Danish: Binocrit anvendes til at behandle anæmi hos voksne, som får kemoterapi for solide svulster, ondartet lymfom eller myelomatose (knoglemarvskræft), og som kan have et behov for en blodtransfusion.
English: Binocrit is used in moderately anaemic adults about to have major orthopaedic surgery (for example hip or knee replacement operations), to reduce the potential need for blood transfusions.
Danish: Binocrit anvendes til voksne med moderat anæmi, som skal have foretaget en større ortopædkirurgisk operation (for eksempel udskiftning af hofte eller knæ), for at nedsætte det eventuelle behov for blodtransfusioner.
English: Patients should be monitored closely to ensure that the lowest approved dose of Binocrit is used to provide adequate control of anaemia and of the symptoms of anaemia.
Danish: Patienterne skal monitoreres nøje for at sikre, at der anvendes den laveste godkendte Binocrit-dosis til at opnå tilstrækkelig kontrol med anæmi og symptomerne på anæmi.
English: Other medicines and Binocrit
Danish: Brug af anden medicin sammen med Binocrit
English: Inject the Binocrit solution as you have been shown by your doctor.
Danish: Indsprøjt Binocrit opløsningen efter lægens anvisning.
English: Binocrit should be administered by the intravenous route.
Danish: Binocrit skal administreres intravenøst.
English: Rare side effects These may affect up to 1 in 1,000 people.
Danish: Sjældne bivirkninger Disse kan forekomme hos op til 1 ud af 1.000 personer.
English: Only take one dose of Binocrit from each syringe discarding unwanted solution before injection.
Danish: Tag kun en dosis fra hver sprøjte, og fjern den overflødige mængde opløsning før injektion.
English: Caution should be exercised with escalation of Binocrit doses in patients with chronic renal failure.
Danish: Der skal udvises forsigtighed, når Binocrit-dosis øges hos patienter med kronisk nyreinsufficiens.
English: Binocrit should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L).
Danish: Binocrit bør administreres for at øge hæmoglobin til ikke over 11 g/dl (6,8 mmol/l).
English: In patients with a poor haemoglobin response to Binocrit, alternative explanations for the poor response should be considered (see section 4.4 and 5.1).
Danish: Hos patienter med et dårligt hæmoglobinrespons på Binocrit skal alternative forklaringer på det dårlige respons (se pkt.
English: “Instructions on how to inject Binocrit yourself” can be found at the end of the package leaflet.
Danish: ”Instruktion i, hvordan du giver dig selv en indsprøjtning med Binocrit” kan ses sidst i indlægssedlen.
English: Binocrit contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”.
Danish: Binocrit indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, det vil sige, den er i det væsentlige natriumfri.
English: • in children on haemodialysis
Danish: • hos børn i hæmodialyse
English: Binocrit is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):
Danish: Binocrit er indiceret til behandling af symptomatisk anæmi i forbindelse med kronisk nyreinsufficiens (CRF)
English: Binocrit should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Danish: Binocrit bør administreres for at øge hæmoglobin til ikke over 12 g/dl (7,5 mmol/l).
English: • Before use, leave the Binocrit syringe to stand until it reaches room temperature.
Danish: • Før brug skal kanylen med Binocrit nå stuetemperatur.
English: Binocrit is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have low serum erythropoietin (< 200 mU/mL).
Danish: hos voksne med primære myelodysplastiske syndromer (MDS) med lav eller intermediær risiko 1, som har lavt serum-erythropoietin (< 200 mE/ml).
English: Only one dose of Binocrit from each syringe should be taken.
Danish: Der må kun udtages én dosis Binocrit fra hver injektionssprøjte.
English: Binocrit should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Danish: Binocrit bør administreres til patienter med symptomatisk anæmi (f.eks. hæmoglobinkoncentration ≤ 10 g/dl (6,2 mmol/l)).
English: Binocrit should be administered as a subcutaneous injection.
Danish: Binocrit skal administreres subkutant.
English: Binocrit should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Danish: Binocrit skal indgives til patienter med anæmi (f.eks. hæmoglobinkoncentration ≤ 10 g/dl (6,2 mmol/l)).
English: Binocrit is one of a group of products that stimulate the production of red blood cells like the human protein erythropoietin does.
Danish: Binocrit tilhører en gruppe lægemidler, som stimulerer produktionen af røde blodlegemer, ligesom det humane protein erytropoietin gør det. Din læge og sundhedspersonalet vil altid notere præcist det lægemiddel, du får.
English: While on Binocrit, some people need medicines to reduce the risk of blood clots.
Danish: Tal med lægen om det. Nogle personer har behov for medicin for at reducere risikoen for blodpropper, mens de tager Binocrit.
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Binocrit dose by 25%.
Danish: Hvis hæmoglobin stiger over 2 g/dl (1,25 mmol/l) pr. måned, eller hvis hæmoglobin vedvarende overstiger 12 g/dl (7,5 mmol/l), reduceres Binocrit-dosis med 25%.
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Binocrit dose by about 25 to 50%.
Danish: Hvis hæmoglobinkoncentrationen stiger med mere end 2 g/dl (1,25 mmol/l) pr. måned, eller hvis hæmoglobinkoncentrationen overstiger 12 g/dl (7,5 mmol/l), skal Binocrit-dosis reduceres med ca.
English: How to use Binocrit
Danish: Sådan skal du tage Binocrit
English: If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Binocrit therapy at a dose 25% below the previous dose.
Danish: Hvis hæmoglobin overstiger 13 g/dl (8,1 mmol/l), skal behandlingen seponeres, indtil niveauet falder til under 12 g/dl (7,5 mmol/l), hvorefter behandling med Binocrit genstartes ved en dosis, der er 25% under den tidligere dosis.
English: If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Binocrit therapy at a dose 25% below the previous dose.
Danish: Hvis hæmoglobinkoncentrationen overstiger 13 g/dl (8,1 mmol/l), skal behandlingen afbrydes, til det falder til under 12 g/dl (7,5 mmol/l), og derefter genoptages med en Binocrit-dosis, som ligger 25% under den tidligere dosis.
English: In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable.
Danish: Hos patienter med kronisk nyreinsufficiens, hvor intravenøs adgang normalt er tilgængelig (hæmodialysepatienter), er intravenøs administration af Binocrit at foretrække.
English: What is in this leaflet What Binocrit is and what it is used for What you need to know before you use Binocrit How to use Binocrit Possible side effects How to store Binocrit Contents of the pack and other information What Binocrit is and what it is used for Binocrit contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Danish: Binocrit indeholder det aktive stof epoetin alfa, et protein som stimulerer knoglemarven til at danne flere røde blodlegemer, der bærer hæmoglobin (et stof, der transporterer oxygen).
English: In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable.
Danish: Hos pædiatriske patienter med kronisk nyreinsufficiens, hvor intravenøs adgang normalt er tilgængelig (hæmodialysepatienter), er intravenøs administration af Binocrit at foretrække.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Danish: Yderligere oplysninger om dette lægemiddel findes på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu og på Lægemiddelstyrelsens hjemmeside http://www.sst.dk>.
English: Where intravenous access is not readily available Binocrit may be administered subcutaneously.
Danish: Voksne peritonealdialysepatienter Hvis intravenøs adgang ikke er umiddelbart tilgængelig, kan Binocrit administreres subkutant.
English: Moreover, in patients with a baseline haemoglobin of > 13 g/dL (> 8.1 mmol/L), the possibility that epoetin alfa treatment may be associated with an increased risk of postoperative thrombotic/vascular events cannot be excluded.
Danish: Desuden kan det ikke udelukkes, at behandling med epoetin alfa kan være forbundet med en øget risiko for postoperative trombotiske/vaskulære hændelser hos patienter med en baseline-hæmoglobinkoncentration på > 13 g/dl (> 8,1 mmol/l).
English: Instructions on how to inject yourself with Binocrit can be found at the end of this leaflet.
Danish: Du kan finde en vejledning om, hvordan du giver dig selv en injektion af Binocrit sidst i denne indlægsseddel.
English: What Binocrit looks like and contents of the pack Binocrit is presented as a clear, colourless solution for injection in a pre-filled syringe.
Danish: Binocrit er en klar, farveløs injektionsvæske, opløsning.
English: Do not administer Binocrit by intravenous infusion or in conjunction with other medicinal product solutions (please refer to section 6.6 for further information).
Danish: Binocrit må ikke administreres som intravenøs infusion eller sammen med andre injektionsvæsker, der indeholder et lægemiddel (se pkt.
English: INFORMATION IN BRAILLE Binocrit 8,000 IU/0.8 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 8.000 IE/0,8 ml
English: INFORMATION IN BRAILLE Binocrit 30,000 IU/0.75 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 30.000 IE/0,75 ml
English: INFORMATION IN BRAILLE Binocrit 7,000 IU/0.7 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 7.000 IE/0,7 ml
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Danish: Binocrit 8.000 IE/0,8 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,8 ml injektionsvæske.
English: INFORMATION IN BRAILLE Binocrit 9,000 IU/0.9 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 9.000 IE/0,9 ml
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Danish: Binocrit 9.000 IE/0,9 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,9 ml injektionsvæske.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Danish: Binocrit 2.000 IE/1 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 2.000 IE epoetin alfa*, svarende til 16,8 mikrogram per ml.
English: INFORMATION IN BRAILLE Binocrit 6,000 IU/0.6 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 6.000 IE/0,6 ml
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/410/013
Danish: Binocrit 8.000 IE/0,8 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/410/013
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Danish: Binocrit 7.000 IE/0,7 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,7 ml injektionsvæske.
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Danish: Binocrit 9.000 IE/0,9 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: Do not shake Binocrit syringes.
Danish: Sprøjterne med Binocrit må ikke omrystes.
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Danish: Binocrit 30.000 IE/0,75 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,75 ml injektionsvæske.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 9,000 IU/0.9 mL injection
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Binocrit 9.000 IE/0,9 ml injektionsvæske
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Danish: Binocrit 40.000 IE/1 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 40.000 IE epoetin alfa*, svarende til 336,0 mikrogram per ml.
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/410/023
Danish: Binocrit 30.000 IE/0,75 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/410/023
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Danish: Binocrit 8.000 IE/0,8 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: INFORMATION IN BRAILLE Binocrit 3,000 IU/0.3 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 3.000 IE/0,3 ml
English: INFORMATION IN BRAILLE Binocrit 40,000 IU/1 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 40.000 IE/1 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 8,000 IU/0.8 mL injection
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Binocrit 8.000 IE/0,8 ml injektionsvæske
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe
Danish: Binocrit 7.000 IE/0,7 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Danish: Binocrit 6.000 IE/0,6 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: INFORMATION IN BRAILLE Binocrit 4,000 IU/0.4 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 4.000 IE/0,4 ml
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Danish: Binocrit 6.000 IE/0,6 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,6 ml injektionsvæske.
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Danish: Binocrit 30.000 IE/0,75 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 40.000 IE epoetin alfa*, svarende til 336,0 mikrogram per ml.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 6,000 IU/0.6 mL injection
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Binocrit 6.000 IE/0,6 ml injektionsvæske
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/410/011
Danish: Binocrit 6.000 IE/0,6 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/410/011
English: INFORMATION IN BRAILLE Binocrit 20,000 IU/0.5 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 20.000 IE/0,5 ml
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/410/019
Danish: Binocrit 9.000 IE/0,9 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/410/019
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Danish: Binocrit 4.000 IE/0,4 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,4 ml injektionsvæske.
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Danish: Binocrit 20.000 IE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 40.000 IE epoetin alfa*, svarende til 336,0 mikrogram per ml.
English: INFORMATION IN BRAILLE Binocrit 5,000 IU/0.5 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 5.000 IE/0,5 ml
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/410/017
Danish: Binocrit 7.000 IE/0,7 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/410/017
English: INFORMATION IN BRAILLE Binocrit 1,000 IU/0.5 mL
Danish: INFORMATION I BRAILLESKRIFT Binocrit 1.000 IE/0,5 ml
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Danish: Binocrit 5.000 IE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 10.000 IE epoetin alfa*, svarende til 84,0 mikrogram per ml.
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/009
Danish: Binocrit 5.000 IE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/410/009
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 3,000 IU/0.3 mL injection
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Binocrit 3.000 IE/0,3 ml injektionsvæske
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa
Danish: Binocrit 30.000 IE/0,75 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Danish: Binocrit 4.000 IE/0,4 ml injektionsvæske, opløsning i fyldt injektionssprøjte